FDA applicant

Kodak Clinical Diagnostics, Ltd.

Buckinghamshire, GB1 decision1995–19950 recalls

FDA records 1 decision for Kodak Clinical Diagnostics, Ltd. (Buckinghamshire, GB) in 1995: 1 510(k) clearance. All are in product code CEC (Radioimmunoassay, Free Thyroxine). No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Kodak Clinical Diagnostics, Ltd.’s devices, and how often a recall has named them.

FDA decisions per year

No FDA decision for Kodak Clinical Diagnostics, Ltd. since 2007.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Kodak Clinical Diagnostics, Ltd. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Kodak Clinical Diagnostics, Ltd.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Kodak”

FDA records each applicant name separately; these may or may not be the same firm.

Kodak Health Imaging Systems, Inc. 6 Kodak-Trophy 1

Kodak Clinical Diagnostics, Ltd.

Which product codes does it file in?

What has FDA decided for it lately?

Other applicant names beginning “Kodak”